Peripheral Artery Disease (PAD) is unequivocally a global pandemic. Over 200 million people worldwide are afflicted by PAD, and prevalence has grown over 25% in the last decade. At Spectranetics, we are focusing on proven algorithms of treatment for the most complex and challenging cardiovascular cases.